SILO

Silo Pharma, Inc.

Healthcare · Biotechnology

$208.59 sample

+0.80 (+0.39%) 1D

Market cap

$1.23T

Price as of

2026-10-03

Latest filing

8-K · 2026-09-03

Alerts

8

Price$208.59 -2.38% 3M daily closessample

226.21207.79

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28INSInsider sell: 10% owner
Sep 21INSInsider sell: EVP, Operations
Sep 14INSInsider sell: Chief Executive Officer
Sep 09INSInsider sell: EVP, Operations
Sep 03SEC8-K filed: material event
Aug 28INSInsider buy: Director
Aug 21INSInsider sell: Chief Financial Officer
Aug 14SEC10-Q filed

Sign up to see the real SILO record →

Company facts

SEC EDGAR registration

Name: Silo Pharma, Inc.
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -15sample, -100 to +100
Reporting currency: USD

Who is positioning in SILO

sample

Insiders: 16 insider transactions over 90 days, net selling, $862.9M
Congress: 2 members traded over 90 days
Institutions · 13F: 7 funds hold $11.4B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$63.6B +18.1% y/y

Q4 2024Q3 2026

Inventory$37.9B +15.8% y/y

Q4 2024Q3 2026

Accounts receivable$28.8B +21.1% y/y

Q4 2024Q3 2026

Total debt$71.5B +12.2% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.19T +0.9% 3M
Sample peer B: $1.08T +9.9% 3M
Sample peer C: $496.6B +12.5% 3M
Sample peer D: $1.16T +13.8% 3M
Sample peer E: $777.2B +8.7% 3M